HGG-21. GERMLINE MUTATIONS IN MSH2 GENE IN PEDIATRIC PATIENTS WITH CONGENITAL AND SPORADIC GLIOBLASTOMA

INTRODUCTION: Glioblastoma (GBM) remains one of the biggest therapeutic challenges in neuro-oncology. In spite of multimodal treatment approaches the prognosis of GBM is extremely poor, median survival is estimated about 12–16 months. Although GBM is one of the most common and malignant primary brai...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Neuro Oncol
Main Authors: Ejmont, Maria, Rydzanicz, Małgorzata, Grajkowska, Wiesława, Perek-Polnik, Marta, Sowińska, Agnieszka, Kozłowska, Magdalena, Łastowska, Maria, Pronicki, Maciej, Płoski, Rafał, Dembowska-Bagińska, Bożenna, Trubicka, Joanna
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2020
Teme:
High Grade Glioma
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715741/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.308
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki